Despite expectations to the contrary, a new survey from cardiovascular healthcare consulting firm MedAxiom finds that overall, cardiology compensation continues to increase. The company’s fifth annual Cardiovascular Provider Compensation and Production Survey also revealed that one in five cardiologists is over the age of 61, and that overall compensation for private cardiologists is increasing faster than that of their integrated counterparts; the differential in compensation is at its lowest point in five years.
October 3, 2017 – Medical Metrics, an experienced core laboratory for multi-center clinical trials, has implemented the ...
October 2, 2017 — Cardiovascular healthcare membership organization and performance community MedAxiom announced its ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S. Food and ...
Medtronic plc recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro valve in everyday clinical practice. Studying patients with severe symptomatic aortic stenosis at an intermediate, high or extreme risk for open-heart surgery, the FORWARD PRO Clinical Study will evaluate longer-term performance (out to five years) of the next-generation self-expanding transcatheter aortic valve implantation (TAVI) system, which was recently approved for commercial use in Europe and United States.
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 2, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...
September 29, 2017 — TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the premarket ...
Avinger Inc. recently announced Conformité Européenne (CE) Marking approval for treating in-stent restenosis with the Pantheris Lumivascular atherectomy system.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 28, 2017 — New research revealed that on average, more than 75 percent of people aged 65 and older worldwide ...
Farouc Jaffer, M.D., Ph.D., director of coronary interventions at Massachusetts General Hospital, discusses the newest ...
September 28, 2017 — The AstraZeneca HealthCare Foundation’s Connections for Cardiovascular Health (CCH) program is ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the Impella RP heart pump. Culminating from five years of research, this approval follows the prior FDA Humanitarian Device Exemption (HDE) received in January 2015 and adds the Impella RP heart pump to Abiomed's platform of PMA-approved devices.
September 27, 2017 — Boston Scientific recently launched the Resonate family of implantable cardioverter defibrillator ...
Toshiba Medical announced it will highlight several of its latest vascular and interventional imaging solutions at the 2017 Annual Meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago.